We are proud to inform you that our product BreastIHC is now CE-IVD cleared! This makes Mindpeak the first company to have approval for Deep Learning-driven IHC quantification of the proliferation markers Ki-67, Estrogen and Progesterone in breast tumor that can distinguish tumorous and non-tumorous cells in single-stained IHC slides. BreastIHC is a plug-and-play software that works across most stainers and scanners without parameterization or retraining. This is an enormously important step in our company's short history of only 3 years!